MiRNAs and Muscle Regeneration: Therapeutic Targets in Duchenne Muscular Dystrophy

被引:21
|
作者
Aranega, Amelia Eva [1 ,2 ]
Lozano-Velasco, Estefania [1 ,2 ]
Rodriguez-Outeirino, Lara [1 ,2 ]
Ramirez de Acuna, Felicitas [1 ,2 ]
Franco, Diego [1 ,2 ]
Hernandez-Torres, Francisco [1 ,2 ,3 ]
机构
[1] Univ Jaen, Fac Expt Sci, Dept Expt Biol, Paraje Lagunillas S-N, Jaen 23009, Spain
[2] Medina Fdn, Technol Pk Hlth Sci,Av Conocimiento 34, Granada 18016, Spain
[3] Univ Granada, Fac Med, Dept Biochem & Mol Biol & Immunol 3, Avda Invest 11, Granada 18016, Spain
关键词
microRNA; satellite cell; myogenesis; muscle regeneration; muscular dystrophies; REGULATES MYOBLAST PROLIFERATION; NECROSIS-FACTOR-ALPHA; LONG NONCODING RNA; SKELETAL-MUSCLE; SATELLITE CELLS; STEM-CELLS; MYOGENIC DIFFERENTIATION; GENE-EXPRESSION; DOWN-REGULATION; TRANSCRIPTION FACTOR;
D O I
10.3390/ijms22084236
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
microRNAs (miRNAs) are small non-coding RNAs required for the post-transcriptional control of gene expression. MicroRNAs play a critical role in modulating muscle regeneration and stem cell behavior. Muscle regeneration is affected in muscular dystrophies, and a critical point for the development of effective strategies for treating muscle disorders is optimizing approaches to target muscle stem cells in order to increase the ability to regenerate lost tissue. Within this framework, miRNAs are emerging as implicated in muscle stem cell response in neuromuscular disorders and new methodologies to regulate the expression of key microRNAs are coming up. In this review, we summarize recent advances highlighting the potential of miRNAs to be used in conjunction with gene replacement therapies, in order to improve muscle regeneration in the context of Duchenne Muscular Dystrophy (DMD).
引用
收藏
页数:23
相关论文
共 50 条
  • [1] THERAPEUTIC TARGETS FOR DUCHENNE MUSCULAR DYSTROPHY (DMD)
    Brown, A. E.
    Sorbera, L. A.
    DRUGS OF THE FUTURE, 2013, 38 (06) : 395 - 406
  • [2] REGENERATION OF MUSCLE IN DUCHENNE MUSCULAR-DYSTROPHY
    KAKULAS, BA
    MASTAGLIA, FL
    PAPADIMITRIOU, JM
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1974, 33 (01): : 194 - 194
  • [3] Potential therapeutic targets for hypotension in duchenne muscular dystrophy
    Saxena, Harshi
    Weintraub, Neal L.
    Tang, Yaoliang
    MEDICAL HYPOTHESES, 2024, 185
  • [4] Macrophages in the Context of Muscle Regeneration and Duchenne Muscular Dystrophy
    Hernandez-Torres, Francisco
    Matias-Valiente, Lidia
    Alzas-Gomez, Virginia
    Aranega, Amelia Eva
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (19)
  • [5] Therapeutic potential of miRNAs in Duchenne muscular dystrophy and other neuromuscular diseases
    Xia, Yuxing
    JOURNAL OF PHYSIOLOGY-LONDON, 2021, 599 (05): : 1377 - 1378
  • [6] REGENERATION IN DUCHENNE MUSCULAR DYSTROPHY
    MASTAGLI.FL
    PAPADIMI.JM
    KAKULAS, BA
    AUSTRALASIAN ANNALS OF MEDICINE, 1968, 17 (02): : 172 - &
  • [7] Circulating Muscle-specific miRNAs in Duchenne Muscular Dystrophy Patients
    Li, Xihua
    Li, Yuying
    Zhao, Lei
    Zhang, Duo
    Yao, Xuan
    Zhang, Huihui
    Wang, Yu-cheng
    Wang, Xin-yi
    Xia, Hongfeng
    Yan, Jun
    Ying, Hao
    MOLECULAR THERAPY-NUCLEIC ACIDS, 2014, 3 : e177
  • [8] Characterization of muscle-specific expression of miRNAs in Duchenne muscular dystrophy
    Maciotta, S.
    Meregalli, M.
    Farini, A.
    Belicchi, M.
    Parolini, D.
    Bresolin, N.
    Torrente, Y.
    NEUROMUSCULAR DISORDERS, 2007, 17 (9-10) : 841 - 841
  • [9] Epigenetic modifications in muscle regeneration and progression of Duchenne muscular dystrophy
    Anna Rugowska
    Alicja Starosta
    Patryk Konieczny
    Clinical Epigenetics, 2021, 13
  • [10] Epigenetic modifications in muscle regeneration and progression of Duchenne muscular dystrophy
    Rugowska, Anna
    Starosta, Alicja
    Konieczny, Patryk
    CLINICAL EPIGENETICS, 2021, 13 (01)